BioCentury
ARTICLE | Product Development

Crossing boundaries: BBB shuttles come of age

Swell of activity suggests the blood-brain barrier could become a drug gateway

October 15, 2025 12:04 AM UTC

CNS drug development holds few challenges that are wider-reaching and longer-standing than the inability to deliver therapies to the brain.

Critical to protecting the fragile, energy-intensive brain cells that make us who we are, the blood-brain barrier (BBB) is indispensable for life. It’s also a major frustration for drug developers...